Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
F. Nicholas Franano, MD, is a physician, scientist, inventor and entrepreneur. He is President and CEO of Flow Forward Medical, a company developing the Arteriovenous Fistula Eligibility (AFE) System™, a medical device designed to rapidly establish high-quality vascular access sites for hemodialysis patients. Dr. Franano also serves as President and CEO of Metactive Medical, a company developing novel, endovascular medical devices for the treatment of peripheral vascular and neurovascular diseases.
Cardiovascular diseases, interventional radiology, peripheral vascular and neurovascular diseases, Congestive Heart Failure
Research Article: Cardiovasc Pharm Open Access 2016, 5: 178